Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 306.16B, Merck(MRK) trades at $121.56. The stock has a price-to-earnings ratio of 16.45 and currently yields dividends of 2.7%.
As of 2026-02-07, Merck(MRK) stock has fluctuated between $119.25 and $122.66. The current price stands at $121.56, placing the stock +1.9% above today's low and -0.9% off the high.
The Merck(MRK)'s current trading volume is 13.08M, compared to an average daily volume of 16.08M.
In the last year, Merck(MRK) shares hit a 52-week high of $122.66 and a 52-week low of $73.31.
In the last year, Merck(MRK) shares hit a 52-week high of $122.66 and a 52-week low of $73.31.
MRK News
Health Canada has approved Merck's ENFLONSIA (clesrovimab), a monoclonal antibody for the prevention of respiratory syncytial virus (RSV) in newborns and infant...
New insider activity at Merck & Company ( (MRK) ) has taken place on February 6, 2026. Multiple top executives at Merck & Company have recently executed sizabl...
Merck reported significant pipeline progress and new product launches as it prepares for the eventual loss of Keytruda exclusivity. The company expanded its po...
Analyst ratings
55%
of 29 ratingsMore MRK News
Merck (MRK) announced that Health Canada has approved Enflonsia for the prevention of respiratory syncytial virus lower respiratory tract disease in neonates an...
Goldman Sachs analyst Asad Haider raised the firm’s price target on Merck (MRK) to $133 from $120 and keeps a Buy rating on the shares. Merck shares rose 2.2% d...
In recent trading, shares of Merck & Co Inc (Symbol: MRK) have crossed above the average analyst 12-month target price of $92.53, changing hands for $93.13/shar...
Bernstein raised the firm’s price target on Merck (MRK) to $100 from $95 and keeps a Market Perform rating on the shares. The firm notes Merck reported Q4 earni...
Morgan Stanley analyst Terence Flynn maintained a Hold rating on Merck & Company yesterday and set a price target of $109.00. Claim 50% Off TipRanks Premium Unl...
Merck & Company ((MRK)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level data...
In an interview on CNBC’s Mad Money, Robert Davis said Merck (MRK) is starting to see new launches driving growth. The company sees $70B in commercial opportuni...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.